Conformis Product Revenue Slips in 2022

Conformis reported 4Q22 total orthopedic sales and royalties of $17.4 million, +12.9% compared to 4Q21. For the full year, the company's total generated $62.1 million, -37.9% compared to 2021.

The company's product revenue declined -1% for the year as Conformis pivoted to its new sales Platinum Services model and worked through supply...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us